For climate Progressives, Biden s $2.25 trillion isn t enough
Leslie Kaufman and Brian Eckhouse, Bloomberg
April 1, 2021
FacebookTwitterEmail
President Joe Biden delivers a speech on infrastructure spending at Carpenters Pittsburgh Training Center, Wednesday, March 31, 2021, in Pittsburgh.Evan Vucci/AP
(Bloomberg) As a candidate, Joe Biden garnered nearly unanimous support from environmentalists, progressives, and clean energy advocates for his promise to reconfigure the U.S. economy for the fight against climate change.
But as president, his $2.25 trillion jobs-and-infrastructure blueprint released Wednesday and meant to fulfill much of that campaign pledge received a much less harmonious welcome.
“Today I find myself caught between two truths,” said Varshini Prakash, executive director of the youth climate activist group the Sunrise Movement. “This infrastructure plan is a historic step forward that would not have been possible without us,” she said, referring t
Texas power firm Brazos Electric hit with $2.1 billion bill after freeze, files for bankruptcy
Jeremy Hill, Eduard Gismatullin and Rachel Morison, Bloomberg
March 1, 2021
FacebookTwitterEmail
FILE - This Tuesday, Feb. 16, 2021, file photo shows power lines in Houston.David J. Phillip/Associated Press
The largest power generation and transmission cooperative in Texas filed for bankruptcy in the wake of power outages that caused an energy crisis during the winter freeze last month.
Brazos Electric Power Cooperative filed for Chapter 11 in the Texas after racking up an estimated $2.1 billion in charges over seven days of the freeze. Last year, it cost cooperative members $774 million for power for all of 2020.
J&J s COVID-19 vaccine could protect millions - if people take it
One-dose version s overall efficacy is below Pfizer, Moderna
Angelica LaVito and Riley Griffin, Bloomberg
March 1, 2021
FacebookTwitterEmail
Johnson & Johnson’s Covid-19 vaccine could protect millions more Americans from contracting the coronavirus. The key will be assuring people that the single-shot vaccine is worth taking, as its overall efficacy appears lower than the two-dose ones already on the market in the U.S.
J&J’s shot, which U.S. regulators authorized Saturday, is more convenient than the vaccines cleared by the Food and Drug Administration last year. It requires one injection and can be stored for months in a refrigerator. State health officials and the Biden administration see it as a way to quickly host mass clinics as more transmissible virus variants continue to spread. Yet the ease of distributing the vaccine will need to be balanced with the risk of creating the perception that J&J’s sho